Holdings (Monthly)
Guide ↗
Invesco Pharmaceuticals ETF
· Invesco Exchange-Traded Fund Trust| # | Name | Ticker | Since | Shares | Value | % Port | Cat |
|---|---|---|---|---|---|---|---|
| 1 | Invesco Private Prime Fund | N/A | Apr 2025 | 25,081,037 | $25.1M | 6.24% | STIV |
| 2 | Gilead Sciences, Inc. | 375558103 | Apr 2025 | 161,829 | $23.0M | 5.71% | EC |
| 3 | Johnson & Johnson | 478160104 | Apr 2025 | 98,323 | $22.3M | 5.56% | EC |
| 4 | Merck & Co., Inc. | 58933Y105 | Apr 2025 | 201,832 | $22.3M | 5.53% | EC |
| 5 | Pfizer Inc. | 717081103 | Apr 2025 | 803,654 | $21.2M | 5.28% | EC |
| 6 | Amgen Inc. | 031162100 | Apr 2025 | 60,651 | $20.7M | 5.16% | EC |
| 7 | AbbVie Inc. | 00287Y109 | Apr 2025 | 88,295 | $19.7M | 4.90% | EC |
| 8 | Eli Lilly and Co. | 532457108 | Apr 2025 | 18,973 | $19.7M | 4.89% | EC |
| 9 | Abbott Laboratories | 002824100 | Apr 2025 | 159,338 | $17.4M | 4.33% | EC |
| 10 | Liquidia Corp. | 53635D202 | Apr 2025 | 375,819 | $15.9M | 3.96% | EC |
| 11 | Viatris Inc. | 92556V106 | Apr 2025 | 1,061,979 | $13.9M | 3.46% | EC |
| 12 | Bristol-Myers Squibb Co. | 110122108 | Apr 2025 | 235,011 | $12.9M | 3.22% | EC |
| 13 | Amneal Pharmaceuticals, Inc. | 03168L105 | Apr 2025 | 923,920 | $12.6M | 3.14% | EC |
| 14 | Prestige Consumer Healthcare Inc. | 74112D101 | Apr 2025 | 195,296 | $12.6M | 3.13% | EC |
| 15 | Perrigo Co. PLC | G97822103 | Apr 2025 | 883,888 | $12.6M | 3.12% | EC |
| 16 | Supernus Pharmaceuticals, Inc. | 868459108 | Apr 2025 | 248,633 | $12.0M | 2.98% | EC |
| 17 | Harmony Biosciences Holdings, Inc. | 413197104 | Apr 2025 | 318,252 | $11.6M | 2.89% | EC |
| 18 | Biogen Inc. | 09062X103 | Apr 2025 | 63,469 | $11.4M | 2.84% | EC |
| 19 | ANI Pharmaceuticals, Inc. | 00182C103 | Apr 2025 | 138,627 | $11.3M | 2.82% | EC |
| 20 | Collegium Pharmaceutical, Inc. | 19459J104 | Apr 2025 | 246,320 | $11.3M | 2.81% | EC |
| 21 | Amphastar Pharmaceuticals, Inc. | 03209R103 | Apr 2025 | 420,248 | $11.1M | 2.77% | EC |
| 22 | United Therapeutics Corp. | 91307C102 | Apr 2025 | 23,557 | $11.1M | 2.75% | EC |
| 23 | Regeneron Pharmaceuticals, Inc. | 75886F107 | Apr 2025 | 14,775 | $11.0M | 2.72% | EC |
| 24 | Innoviva, Inc. | 45781M101 | Apr 2025 | 527,232 | $10.5M | 2.62% | EC |
| 25 | Ligand Pharmaceuticals Inc. | 53220K504 | Apr 2025 | 54,255 | $10.4M | 2.59% | EC |
| 26 | Jazz Pharmaceuticals PLC | G50871105 | Apr 2025 | 62,017 | $10.2M | 2.54% | EC |
| 27 | Travere Therapeutics, Inc. | 89422G107 | Apr 2025 | 313,637 | $9.8M | 2.42% | EC |
| 28 | Invesco Private Government Fund | N/A | Apr 2025 | 9,426,686 | $9.4M | 2.34% | STIV |
| 29 | Tarsus Pharmaceuticals, Inc. | 87650L103 | Apr 2025 | 136,718 | $8.8M | 2.19% | EC |
| 30 | Ocular Therapeutix, Inc. | 67576A100 | Jan 2026 | 927,738 | $8.5M | 2.11% | EC |
| 31 | Corcept Therapeutics Inc. | 218352102 | Apr 2025 | 144,438 | $5.8M | 1.43% | EC |
| 32 | Invesco Government & Agency Portfolio | 825252885 | Apr 2025 | 139,213 | $139K | 0.03% | STIV |
| 33 | OmniAb, Inc. | 68218J202 | Apr 2025 | 39,023 | $0 | 0.00% | EC |
| 34 | OmniAb, Inc. | 68218J301 | Apr 2025 | 39,023 | $0 | 0.00% | EC |